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It has long been known that the placenta can function
as an endocrine organ, and human chorionic gonadotropin
(HCG) was the first protein hormone found to have a placental
origin (Saxena, 1971). HCG is secreted by the chorionic
villi of the placenta. In normal pregnancy, HCG begins to
appear in the serum and urine shortly after the first missed
menstrual period. Its level in the urine rises during the
first trimester, reaches a peak around the third month of
pregnancy and gradually declines thereafter. The peak
activity detected in the urine is usually between 30,000
and 50,000 IU/24 hours. However, activities exceeding
1,000,000 IU/24- hours may be found occasionally in patients
with placental disorders such as hydatidiform mole or
choriocarcinoma (Canfield and Morgan, 1973). The etection
of HCG in blood or urine of men, post-parturitive women or
prepubertal children constitutes presumptive evidence for
the existence of a pathophysiologic state such as neoplasia.
Early pregnancy urine has been the. main source of HCG
used as experimental material for characterisation, activity
and other studies, chiefly because of its easy availability
and high hormonal titre. Partial purification of HCG from
urine can be achieved with the use of various adsorbents
such as benzoic acid, kaolin or permutit (Katzman and Doisy,
1932; Katzman et al,, 194;Loraine and Brown, 1954). These
purification steps usually yield crude HCG preparations
with biological potencies in the range of 2,000-3.000 IU/mg
protein (Canfield and Morgan, 1973). However, for further
purification of the crude HCG, it is necessary to employ
ion exchange chromatography on CM-Sephadex (van Hell et al.,
1968), DEAE-Sephadex A50 (Bahl, 1969; Bell et al., 1969;
Canfield et al., 1971) or DEAE cellulose (Mori, 1970) in
conjunction with gel filtration through Sephadex G-100 (van
Hell et al., 1968; Bahl, 1969; Mori, 1970) or Bio-Gel (Bell
et al., 1969; Canfield et al., 1971). The highly purified
HCG preparations obtained by these methods have biological
potencies ranging from 12,000 to 18,000 IU/mg protein. More
recently, Qazi et al. (1974), employing preparative iso-
electric focusing on sucrose density gradient followed by
gel filtration on Sephadex G-100, obtained a preparation
assaying up to 17,000 IU/mg protein, while Okumura et al.
(1973) claimed that a preparation with activity greater than
20,000 IU/mg protein could be obtained by chromatography on
Amberlite CG-50 and Sephadex G-100. This probably represents
the upper limit for the specific activity of HCG.
Urinary HCG is a glycoprotein with a carbohydrate con-
tent of approximately 25 to 31 g/lOOg of hormone (Canfield
and Morgan, 1973). The carbohydrates include L-fucose,
D-galactose, D-mannose, N-acetylglucosamine, N~acetyJgalac-
tosamine and sialic acid; these units are linked to the
polypeptide by either N-acetylglucosaminyl asparagine or
N-acetylgalactosaminyl serine linkages (Bahl, 1973). It
has been demonstrated conclusively that the carbohydrate
moieties in HCG are required for the expression of the
hormone's activity ini vivo. Thus, Mori (1970) found that
treatment with neuraminidase abolishes the effect of HCG in
increasing the weight of the seminal vesicles in immature
rats. Kuhn (1971) reported that the ability of HCG to de-
plete rat ovarian ascorbic acid is related to the sialic
acid content of HCG from sera and chorionic tissues obtained
during different terms of pregnancy. More recently, van
Hell (1974) showed that the removal of sialic acid residues
from different locations in the carbohydrate chains may lead
to varying degrees of lessening of the potency of HCG in
increasing the weight of rat seminal vesicles. The exact
manner in which the carbohydrates affect the in vivo hor-
monal activity is not clear, For glycoprotein hormones
such as FSH and HCG, it has been suggested (Morell et al.,
1971) that the carbohydrates serve only to protect the
hormone from degradation by serum proteolytic enzymes and
play no contributory role in its biological activity per-
se. However, Marz et al. (1973a) showed that in the case
of HCG, the mannose residues appear to be intimately in-
volved in the. binding of the hormone to ovarian receptors..
Whether the carbohydrates participate in any other capaci-
ties or not remain to be seen.
Like some tropic hormones of pituitary origin such
as FSH, LH and TSH, HCG consists of two subunits, HCG-d and
HCG-9, which are non-covalently linked to each bther. The
two subunits can be dissociated by incubation with 8M urea
and are readily separable by chromatography on DEAE-Sephadex.
Each subunit thus obtained can be freed of any undissociated
hormone by gel filtration on Sephadex G-100 (Swaminathan and
Bahl, 1970; Morgan and Canfield, 1971). The two subunits
are non-identical as shown by differences in molecular weight,
amino acid compositionand peptide map patterns.
Using polyacrylamide disc gel electrophoresis in sodium
dodecyl sulphate and gel filtration on Sephadex G-100, Canfield
et al. (1971) demonstrated that HCG-3 has a higher apparent
molecular weight than HCG-d. Bahl (1973) found that:the
c-subunit contains considerably higher amounts of lysine,
histidine, glutamic acid, methionine, tyrosine and phenyl¬
alanine, while the £-subunit is richer in arginine, proline,
isoleucine and leucine. He also found that there is a larger
amount of sialic acid and galactose in HCG-3 than in HCG-d.
Furthermore, HCG-? contains N-acetylgalactosamine and fucose
which are absent from HCG-d, Dansylation studies (Morgan
and Canfield. 1971; Bellisario et al., 1973) showed that the
U-subunit has serine as its N-terminal amino acid although
alanine is also found in the' same position, albeit to a
smaller extent. Similarly, alanine was found to be the main
amino acid in the N-terminal of the HCG-d subunit although
significant amounts of aspartic acid and .valine have been
detected. Morgan et al. (1973) and Ashitaka (1974a) showed
that both HCG-ot and HCG- exhibit heterogeneity on analytical
disc gel electrophoresis. This heterogeneity has been
attributed largely to differences in the carbohydrate moifety,
especially the sialic acid content. However, the finding
that more than one NH2 -terminal residues can be detected
in each subunit population suggests that some heterogeneity
of amino acid sequence may also exist.
The subunits of HOG, and indeed those of other gonado¬
tropic hormones, have some interesting immunological and
biological properties.. Thus, rabbit antisera obtained by
immunizing the animals with HCG can react to a certain
extent with LH (Paul and.Ross1964. Similarly, anti-HCG-d
antisera have been shown by Donini et al. (1975) to react
both with HCG and human LH. By contrast, while anti-HCG-
reacts strongly with HCG-£, it precipitates native HCG only
slightly, and HCG-c4 or LH not at all (Ashitaka et al., 1974a;
Dolais et al., 1974. Thus, it would seem that intact LH
and HCG are immunologically similar, their specificities
governed largely by the d-subunit. This suggests that the
-chains in these two hormones are similar if not identical.
What distinguishes the two hormones are the 3-subunits which
are immunologically distinct.
The above contention was corroborated by biological
studies on the subunits. Neither HCG-« nor HCG-3 possess
any biological activity when free (Morgan et al., 1974),but
upon recombination of the subunits, most of the original
biological activity is regained. Thus, neither subunit show
any appreciable binding to target cells in vitro (Catt et 1.,
1973) while the reconstituted hormone binds strongly. Further¬
more, when the d-subunit of one hormone is combined with the
3-subunit of another, the hybrid possssses biological acti¬
vity characteristic of that hormone from which the -subunit
is derived (Vaitukaitis et al., 1973). It seems that the
B-subunit is necessary for the specific hormonal activity
which, however, is expressed only when the ft-subunit.is
combined with an U-subunit.
The chemical and biological studies mentioned above
were carried out with KCG from urinary source. To-date,
relatively little work has been done with HCG from placental
extracts. In terms of chemical characteristics, Ashitaka
et al. (1972) showed that HCG from hydatid!form mole, a
hyperplastic condition of placenta, differs from normal
urinary HCG both in the nature and content of carhohydrates.
More recently, Ma et al. (personal communication) found that
molar HCG contains glucose which is not present in the
urinary hormone (Bahl, 1973).. According to Ashitaka (1970),
HCG from normal chorionic tissue Is again different from
molar HCG, both in amino acid composition and carbohydrate
content. It was suggested that the differences may be due
to the fact that the two hormones were obtained from chorionic
tissue at different stages of pregnancy.
Where patterns of HCG synthesis is concerned, Vaitukaitis
(1974) found that placental tissues contain large amounts of
free HCG-c£ but without the equimolar amount of HCG-yS expected
if the free oUsubunits had resulted from dissociation of HCG.
The same excess of HCG~ol over HCG-j3 in normal human chorionic
tissue was independently reported by Ashitaka et al. (1974b).
Furthermore, the relative amounts of HCG- and HCG-£ change
with stages of pregnancy. The nature of this excess of HCG-ci
in the placenta remains to be investigated, but these findings
strongly suggest that there is differential genomic activation
during gestation.
In view of these observations, it would seem that if
valid conclustions were to be drawn in the structural func-
tionalism of HCG, the hormone obtained from the original
source, namely the placenta, must be examined so that com-
parisons may be made with other HCG samples, both respect to
chemical structure and biological activity. The main dif-
ficulties with studies of this kind which have deterred and
stumped many experimenters, are the presence of large amounts
of extraneous proteins in placental extracts and the difficulty
in obtaining placentas during the peak production of the
hormone, that is, during early pregnancy., At term, the amount
of HCG in each placenta has dropped to such a low level that
an inordinately large bulk of starting material is required
to yield enough quantities of HCG for biochemical studies.
For this reason, studies concerning placental HCG are still
mainly confined to establishing methods for purification.
Ashitaka (1970) obtained, by percolation and ion-
exchange chromatography, two fractions of HCG from term
placentas with biological potencies of 96 and 300 lUmg.
The same preparations assayed radioimmunologically at 72
and 92 IUmg respectively. Flury and Martin (1972) reported a
product assaying at a biological potency of 38 IUmg after
a series of purification steps including water extraction,
fractionation with ethanol and ammonium sulphate, and Sephadex
G-100. In 197, Lee et al,, using ion-exchange chromatography
and gel filtration, obtained a preparation assaying immuno¬
logically at 189 IUmg, the highest activity reported thus
far.
As seen from these reports, the HCG preparations iso¬
lated from placentas have a much lower specific activity
than those obtained from pregnancy urine. This has generally
been attributed to the low specificity of the starting
material, and the inadequacy of the purification procedures
employed. Lunenfeld and Eshkol (1967) have observed that
the final activity of a-gonadotropic preparation depends
upon the activity of the starting material. It is not
surprising then, in the isolation of HCG from human term
placenta, with its low HCG content and large quantity of
extraneous proteins, to find that the specific activity of
the product is less than satisfactory. Another drawback
common to the published purification procedures is the low
yield: normally, the total activity in the final preparation
amounts to no more than 15-20% of that in the crude placental
extract. This is due of course to the large number of chroma¬
tographic steps involved. In view of this, it is imperative
that new purification methods be found for HCG which would
yield a product of high potency and which would not claim an
excessive loss of the biologically active material.
While any or all of the above factors undoubtedly con¬
tribute towards the low specific activity of the placental
HCG preparations reported, the possibility that this 'low1
potency is an intrinsic property of the HCG molecule in the
placenta cannot be ignored, especially in view of the findings
of Vaitukaitis (1974) and Ashitaka (1974b) mentioned earlier.
To test the validity of this hypothesis, it is necessary to
ascertain the homogeneity of the final product. With glyco¬
proteins, the usual criteria for protein purity such as
crystallization, salt-out curves and sharp bands, in disc gel
electrophoresis, do not give clear-cut answers. Other methods,
such as the determination of the number of N-terminal amino
acids in the final preparation must be employed in conjunction.
The first part of the present investigation was devoted
to the purification of HCG from human term placenta and its
characterization with respect to amino acid composition,
N-terminal amino acid determination and immunological cross-
reactivity with HCG from urinary and molar sources. The
purification technique adopted was the highly specific
method of affinity chromatography.
Affinity chromatography is a relatively recently
developed technique for the isolation and purification of
biologically active substances (Cuatrecasas et al., 1968;
Cuatrecasas, 1970). It is based on the principle that
proteins can bind ligands specifically and reversibly. Thus,
unlike standard purification methods which depend on
physicochemical differences between proteins, this specific
adsorption method exploits the unique property of selective
binding. In this method, a crude extract of the biologically
active substance to be isolated is passed through a column
containing a water-insoluble polymer to which a ligand
specific to the macromolecule of interest has been convalently
coupled. Those molecules not exhibiting any specificity for
the bound ligand will pass on through the column, while those
molecules having a binding affinity for the ligand will be
retarded to an extent governed by the binding constant of the
macromolecule for the ligand under the experimental conditions,
The specifically adsorbed macromolecules can be eluted from
the column by changing the solvent conditions such as ionic
strength and pH, by the addition of competitive inhibitor or
substrate to the eluant, or by incorporating into it protein
denaturants such as urea, guanidinium chloride, or detergents.
In some cases, elution can be achieved simply by changing the
temperature of elution.
In principle, affinity chromatography can be used for
the purification of enzymes, antigens, antibodies, nucleic
acids, cofactor- or vitamin-binding proteins, hormones or
hormone receptors and even cell populations. For successful
application of this technique, the particular experimental
conditions to be used must be carefully chosen. Consideration
must therefore be given to the nature of the solid matrix, the
dependence of the interaction on the structure of the ligand,
the means of covalent attachment, and the conditions selected
for adsorption and elution. The conditions must be such that
the binding affinity between the macromolecule to be isolated
and the ligand should be great enough to prevent its elution
with the nonspecific material, yet it must be weak enough to
permit elution without irreversible denaturation. Detailed
considerations for the choice of the appropriate experimental
conditions have been reviewed by a number of workers including
Cuatrecasas and Anfinsen (1971). Weetall (1973) and Guilford
(1973).
Affinity chromatography offers certain advantages over
the conventional isolation methods. Its high specificity
makes it possible to use but a small amount of adsorbant
material because only a tiny proportion of total protein
from the crude mixture is adsorbed. Furthermore, the
adsorbant can usually be regenerated and used many times.
But perhaps the most important consequence of its specificity
is that usually no more than one or two purification steps
(in the latter case in conjunction with a conventional)
column or another affinity column) are required for the
isolation of product with a high degree of purity. With a
reduction in the number of purification steps, the product
yield is enhanced considerably. Thus, affinity chromatography
would seem to be an ideal procedure for the purification of
placental HCG. In this connection, it is appropriate to note
that affinity chromatography has been applied successfully to
the separation of growth hormone activity from prolactin
(Guyda and P'riesen, 1971) as well as to a single-step isolation
of luteinizing hormone from extracts of ovine pituitary glands
(Gospodarowicz, 1972).
Studies on the physiological action of hormones are
normally difficult undertakings. This is especially true in
the case of HCG because its effect is exerted in the complex
milieu of pregnancy where foetal, maternal and placental
factors interact in the biogenesis of steroid hormones. The
understanding of hormonal effects of HCG in man is further
complicated by its immunological and biological similarity
to human LH. Nevertheless, the biological properties of HCG
have been investigated both in vitro and in vivo by a number
of workers even though the main theme in these investigations
has been the evaluation of the influence of HCG on gonadal
morphology and physiology. Thus, numerous reports have been
published to indicate that following administration of HCG to
the experimental animals, hypertrophy and luteinization of
ovarian interstitial and thecal cells (Newton, 1938),
hypertrophy of testicular interstitial cells (Smith and
Leonard 1930. enlargement of secondary sex organs
(Diczfalusy, 1950 and other such alterations in gonadal
functions are observed.
HOG also appears to play a role in the early development
of the foetal gonads. Information available at the moment
seems to suggest that LH synthesis by the foetal pituitary
starts too late to act as a source of gonadotropic stimulus
for the initial differentiation of the foetal mesenchyme and
HCG must be depended upon to carry out this function. Brody
and Calstrdm (1965) and Wide and Hobson (1971) noted a
correlation between the sex of the foetus and the maternal
serum HCG levels. Villee (1969) theorized that the
development of foetal Leydig cells may be initiated by HCG,
a suggestion supported by observation of an increase in
histochemically active interstitial tissue coinciding with
the increase of HCG levels in the maternal blood and amniotic
fluid (Niemi et al., 1967). The decrease in Leydig cell
activity after the 17th week of pregnancy might be explained
in the same way, since by that time the HCG level, in maternal
serum and amniotic fluid has also decreased.
The above observations pertain to the LH-like activity
of HCG. It has also been suggested that HCG possesses
FSH-like activity. In neonatally hypophysectomized rats,
administration of HCG has been shown to abet the development
of the ovaries (Albert, 1969; Ashitaka et al., 1970 and
Ashltaka, 1970). Earlier, Faiman et al. (1968) found a high
level of FSH activity in serum during pregnancy and pointed
out that HCG may be responsible for this. By contrast, Jaffe
et al. (1969) did not detect any elevation under similar con¬
ditions. The origin of the FSH-like activity in HCG is still
a point of contention. The possibility that its presence in
these preparations may have arisen from contamination with
pituitary FSH (Crooke and Butt, 1959) or it may be another
product separate from HCG (Robyn et al., 1969) cannot be
ignored.
Another way in which HCG can act to maintain the preg¬
nancy state has been discussed by Mrz et al. (1973b) who
observed a blood-group A-like activity of HCG and suggested
a possible role of HCG in the suppression of maternal lym¬
phocyte function during the implantation of the foetus on
the u.terine endometrium. This immunosuppressive role of
HCG was first postulated by Adcock et al. (1973). but the
validity of this hypothesis remains to be verified.
From evidence thus far available, the most prominent
biological characteristic of HCG is its LH-like activity.
In terms of biochemical responses, this has often been
equated with changes in steroid metabolism in ovarian or
testicular tissues. Savard et al. (1965) showed that HCG
is capable of stimulating progesterone synthesis by corpus
luteum slices in vitro. An in vitro steroidogenic effect
of HCG has also been observed in human ovarian stromal
tissue (Rice et al., 1964a b) as well as in the testes of
several animal species including man (Brody, 1969; Rosemberg
et al., 1970).
In in vivo studies, measurement of ovarian and peri-
pheral venous progesterone concentrations indicated that the
corpus luteum is the main source of progesterone in the first
twelve weeks of pregnancy (Mikhail and Allen, 1967) and
Yoshimi et al. (1969), studying plasma levels of progesterone
and HCG after the induction of ovulation by gonadotropins
which resulted in single pregnancies, found that HCG may play
an important role in controlling steroidogenesis in this
tissue. This in vivo effect of HCG, however, is apparent-
only during the first four weeks of pregnancy. After that
period, steroidogenesis declines even though HCG levels are
still rising. It would appear that HCG serves to stimulate
the production of progestins by the corpus luteum only to
such a time when placental steroidogenesis reaches a satis¬
factory level and takes over.
In studies on the biochemical effects of HCG or LH for
that matter, relatively little attention has been given to
aspects of ovarian metabolism not directly involving the
steroids themselves. But it scarcely needs mentioning that
factors engaged in the physiological regulation of the ovary
might just as well be expected to act at a variety of sites
in the control of general cellular metabolism as at specific
steps in pathways of steroid hormone biosynthesis. In this
respect, the metabolism of carbohydrate is of special signi¬
ficance because the carbohydrates are both a source of energy
and a source of precursors or cofactors required for steroid
production. Indeed, it has been suggested by Bamberger and
Ahren (1967) that the primary action of HCG in its target
organs may involve a stimulation of their carbohydrate meta¬
bolism, which in turn affects other cellular processes like
steroidogenesis.
In the early 1960s, several papers appeared on the ef¬
fects of gonadotropins on carbohydrate metabolism, particu¬
larly those on glucose and glycogen metabolism. Williams
et al. (1961) reported that HCG can increase the amount of
free glycogen phosphorylase in slices of bovine corpora
lutea, and Stansfield and Robinson (1965) found a decrease
in total glycogen and an increase in phosphorylase activity
in corpora lutea of rats injected with LH. The effects of
gonadotropins on glycolysis in various ovarian preparations
have been reported by a number of workers. Armstrong and
Greep (1962) observed a stimulation of in vitro glucose
uptake and lactic acid productuon by slices of luteinized
rat ovaries when LH was administered in vivo 0.5 to 4 hours
prior to removal of ovaries. Similarly, when LH was added
directly to the medium in which whole prepubertal rat
ovaries were incubated, an increase in lactic acid production
was seen (Armstrong et al., 1963). Bamberger and Ahren (1967)
also demonstrated an enhancement of both glucose uptake and
lactic acid productuon in prepubertal rat ovaries when HCG
was added in vitro. A stimulatory effect of in vivo adminis¬
tration of HCG on in vitro lactate production of the isolated
prepubertal rat ovary has also been reported by Perklev et al.
(1971) as well as by Nilsson and Selstam (1975)
Despite the increasing number of observations on the
stimulatory effect of HCG on ovarian glycolysis, nothing is
known of the exact site and mechanism of action of the hor¬
mone. ince phosphofructokinase (ATP:D-fructose-6-phosphate
1-phosphotransferase, EC2.7-1.11) has been shown to be a key
enzyme in regulating glycolysis (Mansour, 1972), it should
prove interesting to investigate the effect of HCG on the
behaviour of this'regulatory enzyme in the ovary.
The regulation of tissue phosphofructokinase activity
occurs at several levels. In rabbit muscle, the enzyme is
known to exist in multiple molecular forms, the interconver-
sion of which is under the influence of a large number of
modifying ligands. According to Mansour (1972), the fully
active phosphofructokinase is a tetramer which can be rever-
sibly converted to several more highly aggregated forms of
lower specific activity. In addition, the tetrameric form
can be dissociated reversibly at mildly acidic pH to a
dimeric form, again less active than the tetramer. The
interconversion of various molecular forms is a function of
pH, enzyme concentration and concentration of its substrates
and products. Acidic pH (5.8- 6.5) and high ATP level favour
the less active dimeric forms. Reactivation of the enzyme
is brought about by fructose-6-phosphate, fructose-1,6-
diphosphate and the nucleotides ADP and cyclic 3',5',-AMP.
The dissociated enzyme can also recover full activity at
the mildly alkaline pH of 8.0. Formation of the highly
aggregated forms occurs at high concentrations of fructose-
6-phosphate and fructose-1,6-diphosphate. Such an inter-
converting system provides a useful mechanism for the control
of the amount of active enzyme by its substrates and products
without altering its regulatory type of kinetics.
Another level at which phosphofructokinase activity
can be modulated is indicated by its allosteric kinetics
which is affected by a large number of modifying ligands.
Mansour (19?2) reported that ATP inhibits the enzyme by
binding onto allosteric sites which are distinct from the
catalytic site. ATP exerts its effect by decreasing the
affinity of the enzyme for fructose-6-phosphate. At pH 6.9
and under inhibitory levels of ATP, the saturation curve
for fructose-6-phosphate is sigmoidal, indicating homotropic
interaction between the fructose-6-phosphate sites. AMP and
inorganic phosphate decrease the sigmoidicity of the titra¬
tion curve, reflecting the need for ATP production, even at
low fructose-6-phosphate levels, when the 'energy charge' of
the cell is depleted. In this connection, it is interesting
to note that the binding of AMP and ATP to the enzyme is
affected by pH. Thus, ATP binds the enzyme best at acidic
pH (Mansour, 1972), while at pH 8.0, phosphofructokinase
exhibits the Michaelis-Menten type of kinetics.
The fact that phosphofructokinase is also responsive
to the cell's requirement for biosynthetic intermediates is
shown by the inhibitory effect of citrate. At low citrate
levels, the enzyme is maximally active even if the concen¬
tration of ATP is high. However, the inhibitory action of
ATP and citrate is abolished by cyclic AMP. It has been
found (Mansour, 1963 and 1966) that epinephrine activates
phosphofructokinase by increasing the intracellular level
of cyclic AMP.
In molecular terms, the explanation offered to account
for the divers. regulatory phenomenajis that ATP, citrate,
AMP and cyclic AMP share common allosteric sites, albeit
with different binding affinities. This explanation is
teleologically satisfying when one considers the relative
urgency when the organism is faced with an energy deficit,
or a need for biosynthetic intermediates, or an emergency
situation.
A third mechanism by which phosphofructokinase function
can be regulated is through the control of enzyme level in
the tissues. This can be achieved at the biosynthetic or
degradative level. Weber et al. (1966) reported that insulin
induces the biosynthesis of phosphofructokinase in liver.
The induction of de novo synthesis of phosphofructokinase in
the uterus of ovariectomized rat treated with oestrogens has
also been demonstrated by Singhal et al. (196?).
The regulatory role of phosphofructokinase in ovarian
metabolism has not been reported,but in view of the fact
that the activity of phosphofructokinase is modulated at
a variety of levels in a variety of tissues, it seems rea¬
sonable to assume that it may also occupy a crucial position
in the regulation of glycolytic processes in ovaries. The
second part of the present work concerns the effects of in
vitro administration of HCG on the activity of phosphofructo¬
kinase in prepubertal rat ovaries. The mechanism of action
of HCG was also investigated.
As is well known, the expression of the action of poly¬
peptide hormones usually involves a two-messenger system in
which the first messenger, i.e. the hormone, will interact
with the specific effector cells to release a second messen¬
ger which will then perform the hormonal function (Sutherland
et al., 1965). Cyclic AMP or cyclic GMP have been implicated
in this capacity in a variety of tissues. These cyclic
nucleotides are synthesized from the corresponding nucleo-
side triphosphates by membrane adenylate or guanylate cyclase
enzymes in response to hormonal stimulation.
Where HCG is specifically concerned, Marsh et al. (1966)
demonstrated an increase in the concentration of cyclic AMP
in human corpus luteum stimulated In vitro by HCG. An
increase in the production of cyclic AMP in isolated rat
testis was also observed by Dufau et al. (1973) when HCG
was added in vitro. Such an effect was detected prior to the
earliest demonstrable rise in testosterone released. HCG has
also been shown to activate adenylate cyclase in isolated
plasma membranes from bovine corpus luteum (Menon and Kiburz,
1974). in homogenates of luteinized rat ovarian tissue (Danzo,
1970 in ovarian interstitial tissue from pseudopregnant
rabbit (Dorrington and Baggett, 1969). Kawano et al. (1975)
showed a stimulation of both cyclic AMP and progesterone
synthesis in suspensions of rat ovarian interstitial cells
when HCG was incubated with the suspensions in vitro. The
rise in cyclic AMP level was found to precede that of pro¬
gesterone level, suggesting that cyclic AMP is a mediator of
the action of HCG on steroidogenesis. Nugent et al. (1975)
also reported an increase in adenylate cyclase activity in
ovaries of prepubertal rats after in vivo injection of HCG.
If cyclic AMP does mediate the action of HCG, it should
be possible to mimic the effect of HCG on ovarian phospho-
fructokinase activity, assuming that such effects exist, by
6 2'
incubating ovarian slices with cyclic AMP or its N -0
dibutyryl analog. Furthermore, since phosphofructokinase
can be activated in a variety of ways, the exact manner in
which cAMP participates in the regulation process deserves
exploration. This can be achieved by examining the effects
of puromycin and actinomycin D in the hormone- or cyclic AMP-
induced activity changes, or by testing the direct effect of
HCG and cyclic AMP on the ovarian phosphofructokinase extract.
The present investigation was undertaken with two
objectives in mind. The first stems from the desire to
elucidate the mode of action of HCG on the rat ovary. The
second arises as the result of a need for an easy and
reproducible assay procedure for the hormone.
In the course of studying HCG, a number of methods
have been applied for its determination. All are based on
measuring certain ill-defined biological or immunological
activities of the hormone. The bioassays of HCG include
the formation of corpora lutea in immature rat or mouse,
vaginal cornification in immature or adult rat, ovarian
hyperaemia in immature rat and expulsion of ispermatozoa
in amphibia; all of these are qualitative responses. For
quantitative assays, the indices of response commonly used
are the increase in weight of the ovary, uterus, prostate
gland or seminal vesicle after administration of the hor-
mone in vivo to the test animals (Brody, 1969;. Ross, 1973)
These tests suffer from the fact that none is strictly and
absolutely specific for HCG. Furthermore, they require a
considerable number of animals among which variation in
response to the hormone is unavoidable. These conventional
bioassays also require relatively long assaying time and are
expensive in terms of material and man-power.
For immunoassays of HCG (Brody, 1969). the reactions
employed are complement fixation, precipitation, immuno¬
diffusion, agglutination inhibition radioimmunoassay and
fluorescent antibodies. These methods make use of the
antigenic property of HCG and they provide relatively rapid
means for detecting the hormone. While the variance between
individual test animals needs not be considered as the same
batch of testing material is used for each set of assay, the
problem of specificity is not resolved. As has been mentioned,
there is considerable cross-reactivity between IH and HCG.,
Despite the growing popularity of immunoassay, a bioassay
must be accorded its rightful position in measurement of hor¬
mone activities. Bioassay gives a direct indication of the
physiological action of the hormone, and furthermore, it has
been shown that at least for HCG the loss of biological acti¬
vity is not necessarily accompanied by a parallel drop of the
immunological activity (Munshi and Rao, 1967). Recently, in
vitro bioassay systems of HCG based on the steroidogenic
property of the hormone have been described. Dufau et al.
(1972) measured the dose response of testosterone production
in the isolated rat testes. Bajpai et al. (1974) employed
dissociated rat ovarian cells and monitored the amount of
progesterone produced as a function of concentration of HCG
administered. These in vitro bioassay systems are more
economical than the conventional ones. They have the added
advantage that variations in individual responses and the
extraneous factor of differential metabolism of the hormone
in in vivo systems are eliminated. However, the measurement
of testosterone or progesterone still involves tedious procedures.
On the other hand, the assay of phosphofructokinase activity
Is relatively simple. Thus, if the in vitro effect of HCG
on phosphofructokinase activity in rat ovarian slices is
well understood, it may be possible to establish a simple
assaying system for HCG which would have all of the advantages
just mentioned and none of the defects.
MATERIALS AND METHODS
Materials
Analytical grade reagents were used throughout. Urinary
HCG (Lot no. CG-10) was a product of Sigma Chemical Company
(U.S.A.) and Sepharose 6B was purchased from Pharmacia
(Uppsala, Sweden). Activity of HCG was detected using the
latex agglutination inhibition test kit supplied by Organon
Inc. (Holland) under the trade name of Pregnosticon Planotest.
The polyamide sheet (15 x 15 cm) used for N-terminal amino
acid analyses was a product of Cheng-Chin Trading Co. Ltd.
(Taipei, Taiwan). The calibration proteins kit used in SDS
electrophoresis was from SchwarzMann (Orangeburg, New York).
Agar-agar from Serva (Heideberg) was iised in Ouchterlony
double immunodiffusion test. For enzyme assays, the auxiliary
enzymes aldolase (No. A-55H) and triosephosphate isomerase-
glycerophosphate dehydrogenase (No. G-1P81) were purchased
from Sigma.
Animals
White albino rabbits, 3 months old and from a local
source, were used for anti-serum production. Thirty-day-
old female albino rats originating from Simenson Laboratory
(Gilroy, California, U.S.A.) were used in ovarian phospho-
fructokinase studies.
PART I. PURIFICATION OF HCG FROM HUMAN TERM PLACENTA BY
AFFINITY CHROMATOGRAPHY.
Preparation of Crude Placental HCG:
All procedures were carried out at 4 unless otherwise
stated. Human term placentas were obtained from Queen
Elizabeth Hospital and were stored frozen until use. Two
to three placentas were processed at atime. After thawing,
the membranes of the placentas were removed, the tissues cut
into small pieces and thoroughly washed with 0.9$ NaCl. They
were then suspended in distilled xvater to give a total volume
of about 1 litre, and then homogenized in a Waring blender.
The pH of the homogenate was adjusted to 4 with IN HC1, and
the suspension stirred for 1 hour and centrifuged at 8000 xg
for 10 minutes. The supernate was then further adjusted to
pH 3 with freshly prepared 0.5N phosphorifc acid and stirred
for another hour. After removal of the precipitate by cen-
trifugation, the supernate was brought up to 30$ saturation
with ammonium sulphate and the suspension was stirred over¬
night. The brown precipitate formed was discarded and
ammonium sulphate was added to the'supernate to give 70$
saturation. After stirring for overnight, the precipitate
containing the bulk of the HCG activity in the extract was
collected by centrifugation and dissolved in about 100 ml
of distilled water. This protein solution was dialysed
against distilled water for 4-5 days and any precipitate
formed during dialysis was removed. The supernate was tested
for HCG activity with the Pregnostlcon Planotest Kit and
protein content by the method of Lowry et al. (1951)» ad
was then lyophilized to give the crude product. A flow chart
for the preparation of the crude placental pf-oduct is shown
in Fig. 1.
Preparation of Antiserum:
To immunize the rabbits against uHCG, each rabbit was
given weekly subcutaneous injections of 1,000 IU uHCG in
1 ml of a lil (vv) mixture of sterile saline and Freund's
complete adjuvant for the first four weeks. From the fifth
week onward, booster injections were given every third week.
The animals were bled 7 days after each booster shot. The
sera were tested for anti-HCG titres using the HCG-sensitized
latex preparation supplied with the Pregnosticon Planotest
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Kit. The sera became useful when a dilution of 10- to 10
fold was still sufficient to give a positive latex agglutina-
tion test. When the antibody titre had reached this level,
it remained quite constant under the described innoculation
regimen. Antisera of comparable titre were pooled and stored
frozen until use.
Placentas
thawed washed with 0.9% NaCl
Homogenized in Waring Blender
Adjusted to pH with IN HC1
Adjusted to pH 3 with 0.5N HPO
centrifuged (10,000 x g)
Sup e mate
Adjusted to J0% saturation with (NH)2SO stirred overnight
Residue (discarded)
centrifuged (10,000 x g)
Sup e mate Residue (discarded)
Adjusted to 70% saturation with (NH)pSOu stirred overnight
centrifuged (10,000 x g)
Sup e mate Residue
Dissolved in HgO
dialysed against EO






Fig. 1. Scheme for the Production of Crude Placental HCG.
Preparation of Immunoadsorbant:
Before coupling to the Sepharose, the antiserum was
first absorbed with urinary proteins obtained from HCG-free
urine. This was necessary in order to remove IgG molecules
directed against those proteins present in commercial HCG
which might cross-react with proteins in the crude placental
preparation.
Urine samples were collected from non-pregnant women,
pooled and concentrated in an ultra-filtration apparatus.
The concentrated urine was then dialysed exhaustively against
several changes of distilled water and lyophllized. Just
before use, the proteins were dissolved in a minimum amount
of 0.1M borate-saline buffer, pH 8.4. An aliquot was mixed
with antiserum to give a concentration of 0.4 mg protein'ml
serum. The mixture was left standing at room temperature
for 6 hours and then in a refrigerater for a week with
occasional shaking. The precipitate formed was removed by
centrifugation and the supernate was allowed to stand for
another week or two. Any precipitate formed during this
interval was again removed.
The anti-uHCG IgG in the supernate was then concentrated
by precipitation with 40 saturation ammonium sulphate according
to Gospodarowicz (1972). The precipitate was dissolved in
TBS and dialysed against the same buffer overnight. The IgG
preparation thus obtained was examined for its ability to
form precipitin lines with urinary proteins and human serum
albumin in the Ouchterlony double immunodiffusion test. Only
sera which gave negative precipitin reactions were used in
preparing the immunoadsorbait.
The IgG fraction was coupled to Sepharose 6B as described
by Cuatrecasas (1970). About 10 ml of a well-washed suspension
of Sepharose (dry weight 2~3gni) were mixed with an equal volume
of distilled water. To this, 1.5 gm of finely divided cyanogen
bromide were added. During the activation process, the pH of
the reaction mixture was maintained at 11 with 2N NaOH and the
temperature kept at about 20° by adding pieces of ice. The
reaction was essentially complete in about 15 minutes as indi¬
cated by a stabilization of pH. The suspension was then
transferred quickly to a Buchner funnel fitted with several
layers of filter paper and was washed under suction with about
200 ml of cold PBS. The washed, activated Sepharose was
immediately mixed with the treated antiserum and the suspension
was gently agitated for 16 hours at. The coupled Sepharose
was then washed repeatedly with PBS until no more protein
could be detected in-the washing. It was then washed in rapid
succession with 6M urea, PBS and 6e guanidine EC1 and PBS
o
again. The coupled Sepharose was kept at 4 in PBS until use.
Purification of Crude ECG by Affinity Chromatography:
Anti-uECG IgG Sepharose was deaerated, packed into a
column (1 x 10 cm) and equilibrated with PBS at room temperature.
About 1200- 1600 IU of HCG, dissolved in 8 ml of PBS were
charged onto the column. Elution was started by washing the
column extensively with PBS to remove all unadsorbed proteins.
This was followed successively by MgCl (pH adjusted to 6
with NaOH) and 6M guanidine HC1 (pH 1.5). The flowrate was
adjusted to 20 mlhour and the eluates were collected in
fractions of 1.5 ml. The elution was monitored by recording
the absorbance of the eluates at 280 nm with an LKB 8300 UV-
cord II. Elution with a particular solution was continued
until such time as when the absorbance had returned to base¬
line value.
Immediately following elution, the fractions obtained
for each eluting solution were pooled. The PBS- and MgCl-
fractions were dialysed against distilled water. The
guanidine HC1 fraction was adjusted to pH 7 with NaOH and
dialysed against 0.2M ammonium bicarbonate (pH 8.3) for
about 8 days. For each fraction, the protein content was
determined according to the method of Lowry et al. (1951)
and the immunoreactivity was measured using the Pregnosticon
Planotest Kit. The fractions were lyophilyzed and the
products stored at 4°.
Gel Filtration of pHCG on Sephadex G-I00:
The guanidine HC1 fraction was further purified by gel
filtration on Sephadex G-100. Two mg of pHCG was dissolved
in 0.5 ml of 0.2F ammonium bicarbonate (pH 8.3) and applied
onto a Sephadex G-100 column (0.9 x 50 cm) pre-equilibrated
with the same buffer. The column was eluted with same buffer
at a flow rate of 30 mlhour and the eluate was collected in
fractions of 2 ml. The fractions under each absorbance peak
at 280 nm were pooled and tested for protein content and
immunological activity.
Characterization Studies of pHCG:
1. N-terminal Amino Acid Determination.
N-terminal analysis was performed by dansylation of the
protein according to Gray (1967) followed by the identifica¬
tion of the c-dansylated amino acid by polyamide sheet chro¬
matography as described by Woods and Wang (1967). About 0.5
mg polypeptide, dissolved in 0,5 ml of 0. 5F sodium bicarbonate
containing 8M urea, was dansylated by the addition of 0.5 ml
of dansyl chloride solution (20 mgml acetone). The mixture
was left overnight at room temperature; afterwards, the
acetone was removed by evaporation unde£ water suction. The
aqueous solution was desalted by passing it through a Sephadex
G-25 column (1 x 30 cm). Distilled water was used for elution.
The protein fraction was collected, dried and hydrolysed with
50 ul of constant boiling HC1 (6N) in a sealed, vacuated tube
at 110° for 16 hours. The hydrolysate was then dried over
NaOH pellets and redissolved in 10 ;ul acetone-glacial acetic
acid (32, vv). The sample was spotted onto the polyamlde
sheet and developed in a covered tank by ascending solvent
flow employing two solvent systems in perpendicular direc¬
tions. The first dimension was developed with water- 90%
formic acid (100:1.5, vv) for half an hour. After air-
drying the polyamide sheet, appropriate standard dansylated
amino acids were applied. Development in the second dimen¬
sion was effected with benzene- glacial acetic acid (9:1,
vv) for an hour. The separated dansyl amino acids were
visualized under ultraviolet irradiation.
2. Amino Acid Composition Analysis.
The method of Moore and Stein (1951) was employed for
analysing the amino acid composition of the purified pHCG
preparations. Protein samples (1 mg) were hydrolysed with
constant boiling HC1 (6N) for 22 hours at 110° in sealed
vacuated tubes. The hydrolysate was dried under vacuum and
the residue re-dissolved in a measured volume of 0.067M
sodium citrate buffer, pH 2.2. Suitable aliquots were taken
for chromatographic analysis of amino acids on a Beckman
Model 120C amino acid analyser. Acidic and neutral amino
acids were analyzed on the long column (0.9 x 56 cm, Beckman
AA-15 resin) by eluting at a total flow rate of 102 mlhour
with a change of buffer pH from 3.25 to .25. The basic..
amino acids were analyzed on the short column (0.9 x 6 cm,
Beckman PA-35 resin) by eluting at a total flow rate of 102
mlhour with 0.12M sodium citrate buffer, pH 5-25- The peak
areas on the chromatograms were evaluated by the dot-counting
method.
3. Disc Electrophoresis on Polyacrylamide Gel.
The method of Davis (1960 was followed with slight
modifications. for electrophoresis at alkaline pH, 2 ml
of a 7% (wv) ployacrylamide solution in 0.375M Tris-HCl
buffer (pH 8.9) was set to give the separation gel columns
of dimensions 0.5x7 cm. Then, 0.2 ml stacking gel consis¬
ting of 2.5$ polyacrylamide in 0.0625M Tris-HCl buffer at
pH 6.7 was poured on top of each hardened separating gel
and allowed to set by exposing to daylight. The protein
sample of size about 100 ug, dissolved in 0.1 ml of 27%
(wv) sucrose solution, was applied to each gel -tube with
the stacking gel upward. With the anode connected to the
bottom reservoir and the cathode.to the top, electrophoresis
was run at room temperature at a constant current of 3 mA
per tube for about two hours when the tracing dye (0.005$
bromophenol blue) had almost reached the end of the tube.
The gel was then stained with Coomassie Brilliant blue (0.25$)
for two hours and destained in a solution of acetic acid.:
methanol: water (1:3:10).
When the activity of the protein bands was to be deter-
mined, the gel was cut longitudinally into two halves: one
half was stained to reveal the protein bands and the other
half was cut into sections 5 mm long. Each disc was ground
up in FBS, extracted overnight at 4° and centrifuged. The
supernate was tested for immunological activity.
For electrophoresis in low pH gels, 7.5$ polyacrylamide
solution in 0.375E acetate buffer, pH 4.3, was used for set¬
ting the separating gel columns and 2.5$ gel in 0.0625M
acetate buffer, pH 6.7, constituting the stacking gel., The
electrophoretic procedures were similar to those for electro¬
phoresis at alkaline pH except that a running time of 4 hours
was required.
4. SDS Gel Electrophoresis.
The procedures described by Weber and Osborn (1969) was
adopted for determining the molecular weights of the pHCG
preparations by SDS electrophoresis. The gel columns were
set with 10% polyacrylamide solution in 0.05M sodium phosphate
buffer (pH 7.2) containing 0.1% SDS. The proteins (1 mgml)
were first incubated at 37° for 2 hours in 0.01M sodium
phosphate buffer, pH 7-0, containing 1% SDS, it S-mercapto-
ethanol and 4m urea. All the calibration proteins, cytochrome
C, myoglobin, chymotrypsinogen A, ovalbumin and bovine serum
albumin, (10 jug each) were mixed and applied onto one column
while each unknown sample was mixed with cytochrome C only
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and applied to another column. Electrophoresis was conducted
at room temperature at a constant current of 7 mA per tube
for 4- 5 hours. The gel was then stained with Coomassie
Brilliant blue and destained in a solution of acetic acid:
methanol: water (1:3:10).: The relative mobilities of the
calibration proteins were measured and plotted against log
molecular weight. The molecular weight of the unknown
protein was determined from the same plot.
5.Doubie immunodit t'usion.
The technique described by Ouchterlony (1949) was
employed. A 1% agar solution in PBS was used for setting
the agar plate. The peripheral wells were molded at a dis-
tance of 2 cm from the central well. To the central well,
150,u1 of concentrated and absorbed antiserum were applied.
To the surrounding wells, 150 ,ul of antigen preparations
from various sources were added. The plate was then left
at room temperature with occasional inspection until the
immunoprecipitin lines were observable.
PART II. EFFECT OF HCG ON RAT OVARIAN PHOSPHOFRUCTOKINASE
ACTIVITY.
Preparation of Ovarian Extracts:
Female albino rats, 25-30 days old, were sacrificed by
cervical fracture and the ovaries were removed rapidly.
After being trimmed of fat in ice-cold 0.1M Tris-HCl buffer,
pH 8.0, containing 150 mM KC1, 5 mM EDTA and 10 mM 3-mercapto-
ethanol (incubation buffer), they were cut into small pieces
and washed several times faith the same buffer. The slices
were then blotted dry, weighed and divided into the-.required
number of groups. Each group was taken up in the incubation
buffer at about 0 mg tissues per ml. The various groups
were incubated at 37° with the appropriate additions at
concentrations as indicated in Fig. 2 which also shows the
duration of the incubation period for the various groups.
During incubation, the mixtures were gassed with 95% 0-
5% C0£ at intervals of 15 minutes. Following incubation,
the ovarian tissues were homogenized in a glass homogenizer
and centrifuged at -0 000 x g for 10 minutes in a Sorval
RC2B refrigerated centrifuge. The supernate thus obtained
constituted the ovarian extract which was examined for
protein content according to Lowry et al. (1951). These
preparations were immediately assayed for phosphofructo-
kinase activity.
Ovaries
trimmed of fat, washed cut into small pieces
divided into groups to give about 40 mg tissueml incubation buffer
-fbuffer 4-puromycin
Incubation at 37 f°r 30 mins
+ HCG + HCG
-fbuffer -factinomycin D -fdbcAMP
Incubated at 370 for 100 mins






Incubated at 37 for an additional 20 mins Incubated for an
additional 120 mins
Tissues homogenized
centrifuged at 40,000 x g for 10 mins
Supernate Residue discarded
Ovarian extract (0.1 ml used for each enzyme assay)
Fig. 2. Scheme for the Preparation and Assay of Ovarian Phosphofructokinase.
All the additives were dissolved in incubation buffer. The final
concentrations in the incubation mixture were: HCG (2000 IUml);
puromycin (500 jugml); actinomycin D (100 jugml); dbcAMP (8 mM with
1 mM theophylline). For each of the groups shown, a blank was
prepared by substituting incubation buffer for the HCG solution.
These were incubated for an identical period of time as the
corresponding experimental groups.
Enzyme Assays:
For measurement of phosphofructokinase acitvity, the
coupled-assay method as described by Ling et al. (1966) was
followed with no modification except that the concentration
of NADH was 0.05 mM instead of 0.16 mM in the assay mixture.
The auxiliary enzymes were dissolved in 0.01M Tris-HCl buffer,
pH 8.0, containing 0.2 bovine serum albumin to give a solu¬
tion containing in 1 ml 0.25 mg (dry weight) aldolase ana
10 il of triosephosphate isomerase- glycerophosphate dehydro¬
genase suspension. Prior to the assay, 02 ml of this
auxiliary enzymes solution was added to 2.7 ml of reaction
medium containing 33 mM Tris-HCl, 2 mM ATP, 2 mM fructose-
6-phosphate, 5 mM MgSO, 0.05M KC1, 0.05 mM NADH and 1 mM
dithiothreitol to give a total volume of 2,9 ml. The reac¬
tion medium was equilibrated at 28°. Reaction was started
by the addition of 0.1 ml of the phosphofructokinase pre¬
paration.• The rate of change of absorbance of the reaction
mixture at 30 nm was immediately recorded using a Hitachi
Model 139 recording spectrophotometer. When the effect of
various substances on the activities of auxiliary enzymes
was studied, fructose-6-phosphate and ATP were substituted
by 2 mM fructose-1,6-diphosphate.
In preliminary experiments, it was found that the
phosphofructokinase activity in the extract was unstable
even when the enzyme solution was kept in ice. However, the
rate of decay of activity was linear with time. In subsequent
experiments, for each extract examined, at least three deter¬
minations were made and the activity extrapolated to zero
time when the first assay was performed.
One unit of enzyme activity is defined as that amount
of enzyme capable of causing a rate of change of absorbance
of 0.01 per min under the specified conditions..
The results are expressed, wherever possible, as Mean
values+ standard error of the mean. Results within a single
experiment were compared by Student's t-test (between 2 groups)
and a p-value of 0.05 or less was considered as indicative
of significant differences.
RESULTS AND DISCUSSION
PART I. PURIFICATION OF HCG FROM HUMAN TERM PLACENTA BY
AFFINITY CHROMATOGRAPHY.
Preparation of Crude Placental HCG:
A total of 9 placentas have been processed in the
course of this work. The total immunological activity of
HCG isolated by acid and salt precipitation from the indi¬
vidual placenta ranged from 00 to 900 IU, which amounted to
about 80 of that detected in the aqueous placental extract
before treatment. This high yield indicated that neither
low pH nor hi gh ammonium salt concentration have much effect
on the immunological activity of HCG. It has also been shown
by Mori (1970) that the immunological activity of HCG is not
affected by exposing the hormone to pH 3- The lyophilized
placental crude HCG preparations possessed specific activity
in the range of 5 to 13 IUmg which was considerably higher
than that of 0.5- 1 IUmg in the aqueous placental extract.
These crude placental HCG preparations were further purified
by the technique of affinity chromatography.
Preparation of Anti-uHCG IgG Sepharose Column:
Before use, the anti-uHCG antisera were absorbed with
urinary proteins obtained from HCG-free urine in order to
remove any antibodies directed against extraneous proteins
present in the commercial uHCG preparations employed for
immunizing the rabbits.
Following absorption, the immunoglobulins were further
concentrated by precipitation with 40% saturation ammonium
sulphate according to Gospodarowicz (1972). These procedures
maximize the capacity of the affinity column, but more impor¬
tantly, decrease the risk of isolating non-HCG proteins in
the placental extract which might cross-react with urinary
protein.
It may be appropriate to reiterate here that the treated
sera were also tested for immunological reactivity against
human serum albumin, a possible major contaminant in the
placental extract. Only when the treated sera failed to form
precipitin lines in the Ouchterlony double diffusion test
with HOG-free urinary proteins, human serum albumin and
proteins eluted with PBS in a preliminary affinity column
were they deemed suitable for use in the experimental columns.
Fig. 3 shows the chemical reactions involved in the
activation and coupling of ligands onto the Sepharose. Under
the alkaline conditions used for coupling, any unreacted
activated Sepharose would have been converted into the com¬
pletely inactive carbamylated polymer by hydrolysis (Guilford,
1973)t so that when the sample was passed through the column,
no loss of sample proteins should result from their coupling
onto the remaining active functions. That this is indeed the
case was checked in preliminary experiments by treating the
coupled Sepharose with 1M ethaholamine (pH B.O) which would
block the remaining reactive groups if there were any. In
these experiments, it was found that the recovery of proteins
from an affinity column packed with coupled Sepharose treated
with ethanolamine was not different from that with no ethanol-





Fig. 3- Chemical Reactions involved in the Activation and
Coupling of the Sepharose.
After the coupling of the IgG fraction onto Sepharose,
the preparation was washed thoroughly with PBS to remove all
unbound ligands. This was packed into columns of dimensions
1 x 10 cm.
Isolation of pHCG by Affinity Chromatography:
A typical elution profile from an affinity column is
shown in Fig.. Elution with PBS resulted in the emergence
of a broad protein peak which contained no HCG activity as
tested by latex agglutination. When the column was eluted
with 4M MgClg (pH 6), a small protein peak was obtained which
was immunologically active. It was in the 6m guanidine HC1
eluate fraction that the majority of the recoverable HCG
activity was found. It may be noted that when the sample
charged contained more than 1,800 IU of HCG, some activity
could be recovered in the PBS eluate; this was probably due
to the overloading of the column.
Table I shows the specific activities and percentage
recovery in the various fractions from a typical affinity
column, while Table II presents the 95 confidence limits
of these values calculated from ten independent experiments.
As can be seen in Table I, over 90 of the recoverable pro¬
tein were found in the PBS fraction in which no HCG activity
could be detected. On the other hand, 66% of the total
activity was found in the MgCl and guanidine HC1 fractions
which contained only 0.8 of the total protein applied.
These data reflect the high specificity of the affinity
column which retains only those proteins having affinity
for the bound ligands. Thus, only, those molecules capable
of reacting with anti-uHCG antisera were retarded in the
column whilst the bulk of non-specific proteins was washed
Fig.4. Elution Pattern of a Crude Preparation of
HCG extracted from Human Term Placenta.
One hundred and sixty-three mg of protein
in PBS was applied to a column (1 x 10 cm)
of anti-uRCG IgG Sepharose equilibrated with
the same buffer. Eluants used were PBS,4M
MgCl2 and guanidine HC1 as indicated.
Tab1e I
Affinity Chromatography of Crude Placental HCG on an Anti-
































95 Confidence Limits of the Specific Activity and Recovery
of pHCG from Affinity Columns.













Figures in parentheses represent the mean values from ten
independent experiments conducted under similar conditions..
off in the PBS fraction.
To elute the specifically adsorbed proteins, it is
necessary to break down the binding between the proteins
adsorbed and the ligands. According to Avrameas and Ternynck
(1969), most antigen-antibody complexes can be dissociated by
fnyi MgCl2. However, in the present case, elution of the column
with 4m MgCl2 yielded only about 20% of the total activity
charged (Table II). This indicates quite a strong binding
between HOG and its specific antibody, and more drastic con¬
ditions were required for their separation. The use of 6m
guanidine HC1 eluted about 50% of the total activity applied
(Table II), but such conditions are expected to lead to the
dissociation of HCG into its subunits. Hence, the guanidine
HC1 fraction had to be neutralized and dialysed against 0.2M
ammonium bicarbonate (pH 8.3) for reconstituting the hormone.
Within limits, the extent of dialysis determines the recovery.
When the duration of dialysis was increased from 5 to 8 days,
the activity recovered in the guanidine HC1 fraction was
increased from less than 40$ to over 50$» but further dialysis
beyond this period of time did not offer additional improve¬
ment. Despite the extreme elution conditions and the diffi¬
culty in reconstituting the hormone, the column enabled on
the average over 70% of the total activity to be recovered.
The specific activity of_HCG was increased from 9.2 lUmg to
521.7 IUmg in the MgCl eluate and to 489.A lUmg in the
guanidine HC1 fraction.
The specific immunological activity of 521.7 IUmg in
the MgCl fraction is the highest thus far attained for HCG
from term placenta. Ashitaka et al. (1970) reported two pHCG
preparations which assayed immunologically at 72 and 92 IUmg.
The respective biological activities were 96 and 300 IUmg.
Flury and Martin (1972) obtained a product with a biological
potency of 280-392 IUmg. However, the immunological activity
of this preparation is unknown and is probably numerically
lower (Ashitaka et al., 1970). Table II also demonstrates
the reproducibility of the technique of affinity chromato¬
graphy as applied to the present experiments provided that
similar conditions were followed each time. Thus, it appears
that affinity chromatography is a useful tool for the isola¬
tion of HCG from term placenta.
The high affinity between pHCG and anti-uHCG IgG suggested
that it might be possible to examine the extent of similarity
in the determinant areas between HCG's from different sources
by studying the distribution of HCG in the various fractions
eluted from the affinity column.. The reasoning was that if
the different HCG's were immunologically indistinguishable,
they should bind to anti-uHCG IgG to an identical degree. On
the other hand, any immunological dissimilarity would be mani¬
fest in changing elution profiles.
Table III shows the percentage distribution of the
recoverable HCG activity among the PBS, MgCl and guanidine
HC1 fractions when HCG's of placental, molar or urinary origin
were applied to an anti-uHCG IgG Sepharose column. It can
be seen that in no case was activity eluted by PBS. indica¬
ting that the HCG's from these sources were all capable of
binding anti-uHCG IgG. However, their binding affinities
appeared to be different: the column bound uHCG most strongly,
mHCG to a slightly lesser extent and pHCG least, since as much
as 30% of the recoverable pHCG activity were disiodged by
MgCl2 while the corresponding values for mHCG and uHCG were
only about 18% and respectively. The difference in dis¬
tribution between pHCG and uHCG was significant when analysed
statistically (p0.05).
Table III
Percentage Distribution of Recoverable Activity in Various

















Results are given as Mean+ S.E.M.
Figures in parentheses are the number of experiments
performed.
Statistically significant difference when compared with
values for uHCG (p0.05).
These observations indicate that while mHCG and uBCG are
similar, at least in terms of the antigenic property, they
are possibly distinct from the hormone in normal placental
tissue. This'is interesting in view of the fact that both
uHCG and mHCG were derived from chorionic tissue during the
early weeks of pregnancy whereas pHCG was obtained at term.
If the interpretation of the distribution patterns were valid,
it would suggest that the immunological properties of KCG are
different at different stages of gestation. The biological
characteristics of uHCG and the pattern of HCG secretion from
chorionic tissues have previously been shown to vary with the
progress of pregnancy. According to Ashitaka et al. (1970),
uHCG can be fractionated into two biologically active com¬
ponents, one with LK activity, the other FSH activity; but
the ratio of these two components changes with pregnancy, with
the LH-like activity becoming the dominant component at term.
More recently, Vaitukaitis (1970 demonstrated that the placenta
secretes free d-subunits of HCG and that this 'unbalanced1
secretion is especially pronounced in the third trimester.
Our data thus provide corroborative evidence that the form
and the quantity of HCG material manufactured and secreted
by the trophoblastic cells vary according to the physiological
requirement of the pregnant woman.
Purification of pHCG by Sephadex G-100 Column Chromatography:
During the early phase of this work, before the optima]
conditions for operating the affinity column were established,
the specific activity of the product was much lower, in the
region of 130- 250 IUmg. It was deemed desirable to further
subject the product to purification by gel-filtration chroma¬
tography on a Sephadex G-100 column (0.9 x 50 cm). Fig. 5
shows the elution pattern when 2 mg of pHCG from the guanidine
HC1 fraction were charged onto the column, and eluted with 0.2M
ammonium bicarbonate (pH 8.3). Three protein peaks were eluted
but only fraction B contained HCG activity.
Table IV summarises the yield and extent of purification
in three experiments performed. It can be seen that the yield
of the column was low. The result was that the increase in
specific activity of the active fraction was negligible. The
best that could be obtained (Expt. 3) was only about 60. Gel
filtration had been employed successfully for the purification
of HCG from various sources (Mori, 1970; Flury and Martin, 1972
Pala et al., 1972; Qazi et al., 197). The reason for the low
recovery in the present series of experiments was not clear.
With refinements of the affinity column, the need for the






Number of Tubes (2 mitube)
Fig. 5. Elution Pattern of pHCG (Guanidine HC1 Fraction)
on Sephadex C—100. (Expt. 1).
The sample was charged onto a Sephadex G-100 column
of 0.9 x 50 cm and was eluted with 0.2M ammonium
bicarbonate (pH 8 3)• The flow rate was 30mlhour
and eluant collected in fractions of 2 ml. Solid
line indicates protein concentration; broken line
gives the immunological activity.
Table IV
Chromatography of Partially-purified pHCG on a Sephadex G-100 Column.
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Characterization Studies of Purified pHCG:
1. Disc Electrophoresis.
Fig. 6 illustrates the electrophoretic patterns of pHCG
and uHCG In 7% polyacrylamide gel at pH 8.9- The locations
of the active segments in the two samples are also indicated.
It is been that both HCG preparations contain more than one
band. While the activity in the uHCG preparation was asso¬
ciated with a broad diffused zone, that in pHCG was detected
in a region containing three faint bands. The association
of more than one protein bands with the active fraction of
pHCG reflects the so-called microheterogeneity of HCG which
has been shown by Hamashige and Astor (1969) and Graesslin et
al. (1971) to be due to differences in sialic acid content in
the HCG molecules. Another Interesting observation that can
be made from the electrophoretogram is that the overall mobi¬
lity of theproteins in the uHCG sample appears to be higher
than those for pECG. This is consitant with Ashitaka's
observation (1970) that uHCG has a considerably higher sialic
acid content than pHCG.
In addition to the active bands, at least two more bands
with no activity can be observed in both HCG samples. For
uHCG, the two bands exist as minor components in more or less
equal amounts; but in the case of pHCG, the two bands were of
markedly different staining densities. The major one, closer
to the origin, constitutes over 80 of the total proteins






Fig. 6. Disc Electrophoresis at pH 8.9 For pHCG and uHCG.
Gel segments containing immunologically active
proteins are as indicated.
existence of this inactive intensely-staining band would seem
to suggest heavy contamination of the pHCG sample by extraneous
proteins. However, evidence will be presented later to indicate
that this dense band is also derived from HCG. At present, the
hypothesis appears to be gaining acceptance that HCG may either
be a hormone complex or an unstable hormone with 'unpredictable
behaviour (Matthies and Diczfalusy, 1971» Togo, 1969» Graesslin
et al., 1973)- Thus, the bands shown to possess no KCC- activity
by latex agglutination test might actually be variant forms of
HCG or certain components in the hormone complex that are immuno¬
logically different from native HCG and therefore do not react
appreciably with the antisera supplied with the Pregnosticon
Pianotest Kit which are directed against native urinary HCG.
The eleetrophorectic patterns for pHCG and uHCG when
electrophoresis was carried out at pH 4.3 are shown in Fig. 7.
Both samples yielded a broad diffused band with a minor but
faster-moving band, and the uHCG again showed a higher mobility
than pHCG towards the anode. These observations while further
demonstrating the heterogeneous property of HCG and that uHCG
is more negatively charged than pHCG, could offer no further
information than that already discernible with the electro-
phoretic pattern at pH 8.9.
tracing dye
uHCG pHCG
Fig. 7. Disc Electrophoresis at pH K3 for pHCG and uHCG.
2. N-terminal Determination.
The purity of the two pHCG preparations were further
examined by N-terminal amino acid analyses. The positions
and relative fluorescence intensities of the dansylated amino
acids after 2-dimensional chromatography on polyamide sheets
are shown in Figs. 8A (MgC fraction) and 83 (guanidine HC1
fraction). It is seen from Fig. 8A that serine is the major
N-terminal amino acid in the MgCl fraction, constituting
over 80$ of the total -dansylated amino acids detected. Other
N-terminals found are valine and alanine in about equal amounts
together with trace quantities of aspartic or glutamic acid.
For the guanidine HC1 fraction (Fig. 8B), the most intense
spot is also shown to correspond to dansylated serine with
valine and alanine following next in rank— the three making
up over 70$ of the total fluorescence due to the -dansylated
amino acids. Other spots in the same chromatogram are of much
lesser intensities and include dansylated isoleucine, lysine,
phenylalanine ana aspartic or glutamic acid. It appears that,
in both preparations of pHCG, the major component is a poly¬
peptide having serine at its N-terminal while proteins with
alanine or valine at the N-terminals are present in lesser
amounts.
Heterogeneity at the N-terminals of both d- and 3-subunits
of HCG has previously been reported by Morgan and Canfield
(1971) as well as by Bellisario et al. (1973). While serine





H20: 90% HCOOH (100:1.5)
Fig. 8. Two Dimensional Palyamide Sheet Chromatography of Hydrolysates
of pHCG; A, MgClg Fraction; 8, Guanidine HC1 Fraction.
Solvents for development are as indicated. Known dansylated
amino acids applied as standards are: 1, valine; 2, alanine;
3, serine; leucine; 5» lysine; 6, cysteine.
N-terminal of HCG-, that of the J,-subunit was found to con¬
sist mainly of alanine with valine or aspartic acid as alter¬
natives. These amino acids, viz. serine, alanine, valine and
aspartic acid, are also found to be the main N-terminal amino
acids in the MgClg and, to over 70, in the guanidine HC1
fraction of pHCG. These data strongly suggested that HCG and
its subunits are the main constituents in the MgCl fraction
and to over 70% in the guanidine HC1 fraction.
The finding that dansylated serine is the major component
in both pHCG hydrolysates was surprising. There are two
possible explanations. Firstly, since serine is the N-terminal
amino acid of the S-subunit of HCG, our pHCG preparations may
contain an excess of free HCG-3. However, this explanation
is unlikely in view of the work of Vaitukaitis (1970 and
Ashitaka et al. (1974b) who, independently of each other,
showed that there is a marked excess of HCG- relative to
HCG-3 or intact HCG in placental tissue and sera- of pregnant
women, especially toward the end of gestation. Vaitukaitis
(1974), using radioimmunoassay techniques, also demonstrated
a variant form of HCG-c to be present in extracts of chorionic
tissues and that its amount, relative to intact HCG, increases
with pregnancy, so that at term, it can constitute over 90 of
the total HCG material in the tissue. In view of this report,
an alternative explanation for our N-terminal data is proposed.
It is suggested that the major protein band observed in the
disc electrophoretic pattern for pHCG (Fig. 6) is derived from
this variant form of HCG-o(. Furthermore, judging from the
amount of dansyl serine fluorescence, this variant form of
HCG- probably has serine as its N-terminal residue.
The presence of this variant HCG~dt cannot be detected
by the latex agglutination inhibition test since this protein
cross-reacts feebly if at all with intact HCG (Vaitukaitis,
197). However, it would be bound by the affinity column
because the sam protein is found in the uHCG preparation,
albeit to a much smaller extent, so that specific antibodies
were generated against it and were subsequently coupled onto
the Sepharose 6B.
Corroborative evidences for the existence of this
variant RCG- are found in amino acid composition analysis
and SDS electrophoresis experiments.
3. Amino Acid Composition Analysis.
The amino acid compositions of the various preparations
of pHCG were determined, and the results are listed in Table
V together with those reported by Bahl (1973) for uHCG and
its subunits. It can be seen that the amino acid compositions
of the MgCl and guanidine HC1 fractions from the affinity
column are in pretty good agreement with each otherand they
are similar to that obtained by Bahl (1973) for intact HCG
except for the relative amounts of arginine and proline, which
are substantially lower in both pHCG preparations. In the
Table V






































































































Results based on 4 histidine residuesmolecule of HCG.
Data from Bahl (1973)-
MgCl fraction, the leucine content is also decreased.
It is interesting and significant to note, when the
amino acid compositions of free HCG-A and HCG-3 are compared,
that the Jt-subunit contains much less arginine, proline and
leucine. The fact that the variant form of HCG-c reported
by Vaitukaitis (1970 cross-reacts with the authentic c-subunit
indicates that there are similar determinant areas on the two
proteins. Therefore, considerable stretches of the two poly¬
peptide chains must have similar if not identical sequences
of amino acids. In other words, the variant form of HCG-ol
can conceivably have low contents of arginine, proline and
leucine, when compared to HCG-£ or intact HCG.
The amino acid composition data lend further support to
the contention that the major protein in the pHCG preparation-
corresponds to the variant HCG-d. But whereas the authentic
HCG-dl has alanine or valine as its N-terminal amino acid, the
variant form contains serine at this position.
4. Molecular Weight Determination by SDS Electrophoresis.
When SDS electrophoreses were performed for pHCG, uHCG
and mHCG, all samples were found to consist of several com¬
ponents with different molecular weights. The electrophoretic
patterns are shown in Fig. 9- Several features deserve mention.
In the electrophoretogram for uHCG, a total of 6 protein




Fig. 9. SDS Electrophoreses of 2, pHCG (MgCl2 fraction);
3, pHCG (guanidine HC1 fraction); 4, niHCG ana
5, uHCG.
Tube 1 contains calibration proteins: from top
to bottom, the order is bovine serum albumin,
ovalbumin, unknown sample impurity not found in
cytochrome C, chymotrypsinogen A, myoglobin and
cytochrome C. The lower most band in each of
the sample tubes is from cytochrome C.
weights of 20,000 and 33.000 respectively, are readily
identified to have arisen from the d- and 0-subunits of uHCG.
Band b develops from a protein having molecular weight 27,000.
But whereas it occurs as a discrete and relatively minor band
in uHCG, it constitutes the major component in both the MgC
and guanidine HC1 fractions of pHCG (Fig. 9A) and also con¬
tributes significantly towards the total protein in the mHCG
sample (Fig. 9B). Two considerations lead to its assignment
to the variant HCG-cL Firstly, Vaitukaitis (197) showed that
this HCG-c was eluted from a Sephadex G-100 column after HCG-9
but before the authentic HCG-d. The equation of the band b
protein to the variant HCG-ol is consistent with her observa¬
tion. Secondly, since the level of the variant form of HCG-c,
relative to intact HCG, increases continuously throughout
gestation, it should be found as a relatively minor component
in HCG from the urine or trophoblastic tissue obtained during
early pregnancy, but as the predominant HCG material at term.
As can be seen from Figs. 9A and B, this criterion is amply
fulfilled by the band b protein.
Bands d, e and f in Fig.9 correspond to molecular weights
of 50.,000, 68,000 and 80,000 respectively. Judging from their
molecular weights, bands d and e probably represent intact
forms of HCG containing a 5-subunit together with either form
of the dl-subunit, but which have failed to dissociate during
treatment with 1% 3-mercaptoethanol and AM urea. That this
is indeed the case is confirmed in mHCG, where only trace
amounts of bands a and c are found but where band e shows up
as a major band. It is not clear why mHCG should be especially
resistant to denaturing agents, but the matter was not persued.
The nature of band f is not understood. It is perhaps
significant that this protein is found only during early
pregnancy and may correspond to a second variant form of HCG-cJ,
also reported by Vaitukaitis (1970 who showed it to be a
protein larger in molecular size than intact HCG but whose
tissue level drops as pregnancy progresses.
5. Double Immunodiffusion.
Fig. 10 shows the double immunodiffusion patterns of
pHCG, uHCG and mHCG against anti-uHCG antiserum. Two preci¬
pitin lines were observed for uHCG. The assignment of these
bands is a relatively simple matter. When Fig. 10 is viewed
in conjunction with Figs. 6 and 9t it is at once evident that
the outer precipitin line in the uHCG sample arises from the
interaction between intact HCG and its specific antibody.
The inner band is derived from the variant HCG-cl. The fact
that smooth fusion is observed for this precipitin line
between adjacent wells indicates that the variant HCG-ol's
found in these preparations are identical. However, the same
cannot be said for the intact HCG from urine and that in the
MgClg fraction of the placental preparation. A spur is observed
where the two precipitin lines meet. This reveals a certain
degree of dissimilarity between the antigenic determinants
in the native forms of uHCG and pHCG, a suggestion advanced
earlier from the elution patterns in the affinity column,
when it was found that a larger percentage of HCG activity










Fig. 10. Double Diffusion Pattern of pHCG (PBS, MgClg and
guanidine HC1 fractions), uHCG and mHCG.
The central well contained anti-uHCG antiserum;
the various HCG samples were placed in the sur¬
rounding wells as indicated.
Data presented in Fart I of this report suggested that
affinity chromatography is a useful technique for the isola¬
tion of HCG from term placenta. By passing the crude placental
product through a single column, the specific activity of pHCG
was increased by over 50-fol; the yield from such a column
was satisfactory as over 70 of the total activity could be
recovered. The specific immunological activity of about 500
IUmg of the final product is the highest thus far attained
for term placenta but is low compared with that for HCG from
other sources (Pala et al., 1972; Okumura et al,, 1973). Tw°
reasons may be cited to account for this: 1) the immunological
property of pKCG is different from that of uHCG, as witnessed
from the spur in the double immunodiffusion pattern and 2) the
product contains an excess of an apparently homogeneous protein,
which is in all likelihood HCG material, but which is unreactive
in the latex agglutination inhibition test and consequently
dilutes the active protein.
Characterization studies indicated that the product
contains, apart from intact HCG, a protein of molecular weight
27,000. While this protein is not immunologically reactive
against anti-uHCG IgG. it may be ruled out as a non-specific
contaminant unrelated to HCG. In this connection, it should
be remembered that before coupling onto Sepharose 6B. the
antisera were thoroughly absorbed with HCG-free urinary
proteins and had been shown to be free of anti-human serum
albumin IgG. The protein in question therefore cannot be
human serum albumin. The other likely contaminants in the
placental extract are hemoglobin and a chorionic hormone,
human placental lactogen. However, these possibilities are
easily discarded on the basis of molecular weight and nature
of the N-terminal amino acids.
The suggestion was advanced that this protein represents
a variant form of HCG-d first described by Vaitukaitis (1970.
The finding that this protein is much more abundant in term
placenta than in chorionic tissue (hydatidiform mole) and
urine obtained during early pregnancy is in accord with
Vaitukaitis observation (1970 for the variant ECG-dt. Elec-
trophoresis on SD3 gels revealed that this protein has a mole¬
cular size bigger than that of authentic HCG-d but smaller
than that of HCG-3, again what should be expected if it were
the variant dl-subunit. Our data on amino acid composition
further showed a striking similarity between HCG-dt and the
protein in question, a requirement which must be fulfilled if
the two should exhibit cross-reaction.. Taken together, these
observations strongly support the contention that the dominant.
protein found in the placental preparation is indeed a form of
d-subunit of HCG.
The fact that the variant HCG-d is larger than the
authentic d-subunit and possesses a different N-terminal amino
acid is interesting. It is speculated that the variant HCG-o(
represents a prohormone, from which the authentic HCG-d is
derived by removal of a peptide fragment from the NH2-end of
the molecule. However, proof for the validity of this
hypothesis will have to await the preparation of sufficient
material for sequence analysis.
PART II. EFFECT OF HCG ON RAT OVARIAN PHOSPHOFRUCTOKINASE
ACTIVITY.
Effect of uHCG on Rat Ovarian Phosphofructoklnase:
When rat ovarian tissues were incubated, with uHCG at a
concentration of 2000 IUml for twenty mins, and. the subse¬
quent extracts examined, for their abilities to oxidise NADH
in the coupled assay system, a stimulatory effect was observed.
The results are shown in Fig. 11. The increase amounts to
19% and is statistically significant (p0.05).
Since the oxidation of NADH was brought about by the
action of a series of enzymes including phosphofructoklnase
and the auxiliary.enzymes aldolase, triosephosphate isomerase
and glycerophosphate dehydrogenase, the possibility that HCG
might have exerted its effect by enhancing the activity of
these auxiliary enzymes, either directly or through its pre¬
sumed 'second messenger1 cyclic AKP, must be considered. In
later investigations on the mechanism of action of HCG, when
the antibiotics puromycin and actinomycin D were used, it
must be similarly ascertained that their action is confined
to the phosphofructoklnase activity. To demonstrate this,
fructose-1,6-diphosphate was used as substrate instead of
fructose-6-phosphate and ATP in the assay mixture. Tables
VI and VII show the results of these experiments. It can be
seen that when HCG, puromycin, actinomycin D or cAMP were










Fig. 11. Effect of HCG on Rat Ovarian Phosphofructo-
kinase Activity.
Results represent Mean+ S.E.M. of 3 inde¬
pendent experiments., significant dif¬
ference as compared with value of control
(p<0.05).
Table VI
Effect of HCG, Puromycin and. Actlnomycin D on the Activity
of the Auxiliary Enzymes System.
Relative Reaction Rate


















Results expressed as Mean+ S.E.M. from triplicate samples.
p values calculated for the difference in reaction rates
between the experimental and the corresponding control
groups.
Table VII
Effect of cAMP on the Activity of the Auxiliary Enzyme System.
Concentration of cAMP Relative Reaction Rate
0
3 x 10-9M
3 x 10 8m
3 x 10








of the auxiliary enzymes could be detected. It can therefore
be safely concluded that any demonstrable changes in rate of
oxidation of NADH can be attributed entirely to changes in
activity of the phosphofructokinase enzyme.
Following administration of uHCG, both in vitro (Hamberger
and Ahren, 1967) and in vivo (Ferklev et al., 1971; Nilsson and
Selstam, 1975) an enhanced rate of lactic acid production has
been observed in prepubertal rat ovaries. The stimulatory
action of HCG on ovarian phosphofructokinase activity shown
here is probably responsible for the increased glycolytic
rate.
Fig. 11 also shows that HCG is not an allosteric effector
of phosphofructokinase since addition of HCG directly to the
ovarian extract fails to elicit any significant elevation in
enzyme activity. The possibility that HCG acts by promoting
the de novo synthesis of phosphofructokinase enzyme was inves¬
tigated by using substances known to inhibit protein and RNA
syntheses in eukaryotic cells, viz. puromycin and actinomycin D.
Effect of Furomycln and Actinomycin D on the HCG-induced
Increase in Rat Ovarian Fhosohofructokinase Activity:
Fig. 12 depicts the effects of puromycin on rat ovarian
phosphofructokinase activity under various conditions. From
Fig. 12A, it can be seen that when ovarian tissues were










Control HCG HCG Control HCG HCG Puromycin
FIG .12.Effect of Purornycin on HCG-Induced Increase in
Rat Ovarian Phosphofructokinase Activity.
Concentration of HCG used= 2000 IUml; concen¬
tration of purornycin= 500 Jugml. In A, data
shown represent Mean+ S.E.M. of E independent
experiments; in B, data represent Mean+ S.E.M.
of 6 independent experiments., statistically
significant difference as compared with value
of control (p0.01)., statistically signi¬
ficant- difference as compared with value of
sample treated with HCG alone (p0.02).
for 20 mins, the stimulatory Effect of uHCG on the enzyme
activity was not affected. However, Fig. 12B shows that
when the tissues were preincubated with puromycin for JO
mins, followed by 20 mins1 incubation with uHCG, there was
a small (about lQt) but significant (p0.02) lowering of
the apparent hormonal effect. Furthermore, incubation with
puromycin alone did not have any appreciable effect on the
basal level of phosphofructokinase. The amount of puromycin
used was such that the incorporation of amino acids into
ovarian proteins could be blocked completely (Ahren et al.,
1968). The inability of the inhibitor to abolish totally
the stimulatory effect of uHCG suggested that de novo enzyme
synthesis plays but a minor part in bringing about the
observed increase in phosphofructokinase activity in rat
ovarian tissues after incubation with uHCG. Thus, HOG must
have exerted its action on the phosphofructokinase activity
at some levels other than increasing the rate of translation
of the phosphofructokinase-specific mRNA,
The finding that the inhibitory effect of puromycin was
observed only with preincubation is interesting. One possi¬
ble explanation is that puromycin may act by altering the
properties of the HCG-specific receptors on the ovarian cells,
thus affecting the binding of the hormone. However, such a
possibility remains to be investigated.
When the effect of actinomycin D was studied, it was




Control HCG Actinomycin D Actinomycin D
+ HCG
Fig. 13 Effect of Actinomycin D on HCG-induced Increase
in Rat Ovarian Phosphofructokinase Activity.
Concentration of HCG used= 2000 IUml; concen¬
tration of actinomycin D= 100 igml. Data re¬
present Mean+ S.E.M. of 6 independent experi¬
ments., statistically significant difference
as compared with value of control (p0.02).
antibiotic alone does not affect the basal level of phospho¬
fructokinase; actinomycin D also fails to suppress the
stimulatory effect of uHCG to any significant degree. These
observations further confirmed that the hormone-induced
increase in ovarian phosphofructokinase activity is not
the result of a stimulated de novo enzyme synthesis. The
ineffectiveness of both puromycin and actinomycin D on the
enhancing action of LH on rat ovarian glucose uptake and
lactic acid production has also been reported by Ahren et al.
(1969). This observation is not surprising in view of the
present data; it seems that both LH and HCG exert their in¬
fluence on ovarian glycolysis by altering the kinetic pro¬
perties of the phosphofructokinase enzyme.
Effect of Cyclic AMP on Phosphofructokinase Activity in Rat
Ovarian Extract:
It has earlier been shown (Fig. 11) that HCG does not
stimulate phosphofructokinase by acting as an activating
ligand itself. The possibility was raised that it might
exert its influence indirectly, through the mediation of
cyclic nucleotides. It is widely accepted that polypeptide
hormones act primarily via binding to a receptor in the
outer cell membranes with subsequent release of a second
messenger into the cell to carry out the hormonal function
(Sutherland et al., 1965). The presence of HCG receptors
of high specificity and affinity has been demonstrated in
plasma membranes of rat ovarian tissues (Lee and Ryan, 1973;
Koch et ad., 1970 and the binding of HCG to these receptors
has further been correlated with the activation of adenylate
cyclase (Rao and Saxena, 1973 J Koch et al., 197). Such a
stimulatory effect of HCG on ovarian adenylate cyclase acti¬
vity has been associated with the steroidogenic effect of
HCG (Dufau et al., 1973» Kawano et al., 1975) suggesting that
cyclic AMP is a mediator of uHCG action on steroidogenesis.
In view of this, it seems likely that cAMP may also be in¬
volved as the mediator in the stimulatory effect of uHCG on
phosphofructokinase activity.
Since cyclic AMP is an allosteric activator of rabbit
muscle phosphofructokinase (Mansour, 1972), an experiment was
conducted to examine the effect of cAMP on the ovarian phos¬
phofructokinase extract. Table VIII shows that when cyclic
AMP was added directly to the extract at a concentration range
comparable to that expected in the HCG-treated cells, no sig¬
nificant stimulation was observable. This indicates that
under the conditions used for assaying phosphofructokinase,
cyclic AMP is not effective as an allosteric activator, in
agreement with the findings of Mansour (1972) that at pH 8.0,
phosphofructokinase exhibits Michael!s-Menten type of kinetics.
Table VIII
Effect of cAMP on Activity of Phosphofructokinaae in Rat
Ovarian Extract.
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Effect of Dibutyryl Cyclic AMP on Rat Ovarian Phosphofructo-
klnase Activity:
Since dibutyryl cyclic AMP has been shown by Posternak
et al. (1962) to duplicate the action of cyclic AMP but has
the advantages of being capable of penetrating the cell
membrane easily and once inside, is resistant to intracellular
degradation by cyclic nucleotide-specific phosphodiesterase,
it was used instead of HCG in the next series of experiments
designed to further examine the possible involvement of cyclic
nucleotides.
The data presented in Fig. 14 show that when ovarian
slices were incubated with abcAMP, there was a marked eleva¬
tion of phosphofructokinase activity. However, this increase
appears to be qualitatively different from that elicited by
HCG. Whereas the hormone-induced enzyme elevation was only
reduced by 18$ (Fig. 12B), that due to dbcAMP was completely
abolished when puromycin was added to the incubation mixture.
The lack of correspondence in the action of hormone and
the dibutyryl analog of its presumed 'second messenger' is
interesting, but is not without precedent. Differences in
the behaviour of cAMP and its dibutyryl analog has been
reported in their steroidogenic effects in rat adrenal gland
(Pearlmutter et al., 1973)» in their effects on membrane
transport in isolated thyroid cells (Burke et al., 1971) and
also in their effects on glucose uptake and lactic acid pro¬






Fig. 14. Effect of dbcAMP and. Puromycin on Rat Ovarian
Fhosphofructobinase Activity.
Results represent Mean+ S.E.M. of 7 indepen¬
dent experiments., statistically signifi¬
cant difference as compared with value of
control.
It has been suggested (Kaukel et al., 1972) that N-rnono-
butyryl cAMP is the true intracellular imitator of cAMP when
dbcAMP was added to cultured HeLa cells. It has also been
shown that monobutyryl cAMP but not dbcAMP can activate pro¬
tein kinase from bovine brain and heart (Miller et al./1973).
Thus, an intracellular deacylation of dbcAMP seems to be
necessary before it can mimic cAMP in expressing the biologi¬
cal effect. Whether the hydrolysis of dbcAMP to mbcAMP is
spontaneous or enzymatic is still unknown. The detection of
deacylase activity in several rat tissues (Blecher and Hunt,
1972) suggested non-specific enzymatic hydrolysis of dbcAMF
to mbcAMP. If this were true, then one possible way in which
puromycin can abolish the stimulatory effect of dbcAMP on
phosphofructokinase activity might be due to an inhibition
of the enzymatic deacylation of dbcAMP to the active mbcAMP.
Another possibility for the apparent anomalous behaviour
of cAMP and dbcAMP might be due to the higher resistance of
dbcAMP to phosphodiesterase (Posternak et ad., 1962). As a
consequence, the dbcAMP applied in vitro to the ovarian tissue
can exert its action on the protein synthesizing machinery
while the cAMP generated by hormonal action will fail to do
so because it is rapidly inactivated. The observation that
puromycin suppresses the effect of dbcAMP entirely but that
of uECG only moderately is consistent with this hypothesis.
The exact manner in which ECG brings about an enhance¬
ment of the phosphofructokinase activity in prepubertal rat
ovaries remains to be elucidated. The data presented in
Part II of this report have, however, eliminated several
possibilities. It has been shown that neither HCG nor its
second messenger cAMP act directly as allosteric activators
of the enzyme. In addition, it was demonstrated that while
dibutyryl cyclic AMP may increase phosphofructokinase level
by stimulating de novo enzyme synthesis, cyclic AMP generated
in response to HCG administration appears to be incapable of
acting in a similar way, presumably because it was rapidly
destroyed or otherwise removed before It can exert any appre¬
ciable influence on the cellular protein synthesizing machinery.
The slight but statistically significant inhibitory effect of
puromycin on the HCG—induced increase in phosphofructokinase
activity does not invalidate this contention. As mentioned
earlier, puromycin may act by interrupting the binding of HCG
to the ovarian receptors. Alternatively, since phosphofructo¬
kinase is a constitutive enzyme, it Is continuously being
synthesized and degraded. The effect of puromycin may merely
reflect its inhibitory action on the biosynthetic process
which is proceeding at a normal rate even when the ovarian
tissue is under hormonal influence. In this connection, the
complete lack of effect of actinomycin D can be accounted for
by the relatively long life time of mammalian mRNA (Korner,
1970).
The only possibility that remains is that HCG or cAMP
may act to promote the conversion of inactive forms of
phosphofructokinase to the active forms, or alternatively,
by inhibiting the opposite process. This hypothesis is not
without basis. Rabbit muscle phosphofructokinase has been
shown by Mansour (1972) to exist in both active and inactive
aggregate forms. Their interconversion is pH- and ligand-
directed. The basal cellular level of phosphofructokinase
activity represents a balance between the biosynthetic and
activation-inactivation processes. One of the activating
ligands is cyclic AKP. It is therefore suggested that in
rat ovaries, administration of HCG causes a rise in intra¬
cellular level of cAMP. This cyclic nucleotide has two main
functions. At the pH prevailing under physiological condi¬
tions, it can act as an allosteric activator of phosphofruc¬
tokinase. But at the same time, it serves to stabilize
phosphofructokinase in its most active polymeric form. This
second mode of action is manifest in the increase in enzyme
level observed in the present work, in which phosphofructo¬
kinase was assayed at pH 8.0 where cAMF-induced allosteric
activation is not apparent.
SUMMARY
The purification of human chorionic gonadotropin from
term placenta by affinity chromatography was described. In
a single chromatographic step, a 57-fold purification was
achieved. The recoverable activity amounted to over 70%
of that applied. Characterization studies indicated that
the purified product contains the intact hormone as well
as its free ot-subunit. It was demonstrated that HCG in
term placenta is electrophoretically heterogeneous and dif¬
fers immunologically from HCG derived from the urine or
chorionic tissue during early pregnancy. Evidences were
also presented for the existence of a variant form of HCG-d
which has a molecular weight of 27,000; it resembles the
authentic cfc-subunit in having relatively little arginine
and proline, but differs from it in having serine at the
N-terminal.
When the effect of HCG on ovarian carbohydrate meta¬
bolism was studied, it was found that the phosphofructo-
kinase activity in prepubertal rat ovaries is elevated- by
the in vitro administration of HCG. Similar increases were
2'
observed when N -0 -dibutyryl cyclic AMP was used. However,
the two responses appear to be qualitatively different.
While puromycin and actinomycin D have no appreciable effect
on the hormone-induced enzyme enhancement, the stimulatory
effect of dibutyryl cyclic AMP is completely abolished by
puromycin. The data support the hypothesis that the action
of HCG on phosphofructokinase activity is mediated through
cyclic AMP which acts not by increasing the rate of de novo
enzyme synthesis, but probably by favouring the existence
of active forms of the enzyme.
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